pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·Jul 27·1 min read
save

Vaisala executive Vesa Pylvänäinen sells 1,582 shares at €56.92 each

Jul 27, 2026·read at globenewswire health ↗Neutral

Vaisala Oyj disclosed a transaction by senior executive Vesa Pylvänäinen on July 23, 2026.

He disposed of 1,582 ordinary shares of the company on the Nasdaq Helsinki market at an average price of €56.92 per share.

The filing, made through the Finnish securities regulator, is the first such notification for the executive and was announced via the company's investor relations contact.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Vaisala Oyj: Johtohenkilöiden liiketoimet – Pylvänäinen, Vesa”

read at globenewswire health ↗
138 words · retrieved Jul 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • Aug 10Aspo Oyj - Johdon liiketoimetglobenewswire health
  • Aug 10Aspo Plc - Managers' Transactionsglobenewswire health
  • Aug 7Ledende medarbejder transaktionglobenewswire health
  • Aug 7Ledende medarbejders køb af aktierglobenewswire health
  • Aug 6Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officerglobenewswire health